DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: KESIMPTA (ofatumumab)
       *****************************************************
       #Post#: 5021--------------------------------------------------
       (Abst.) 6-year safety and efficacy outcomes w/first-line ofatumu
       mab in recently diagnosed pts. w/relapsing MS
       By: agate Date: December 13, 2025, 1:13 am
       ---------------------------------------------------------
       From PubMed (December 12, 2025)--"Six-year safety and efficacy
       outcomes with first-line ofatumumab in recently diagnosed
       treatment-naive patients with relapsing multiple sclerosis":
  HTML https://pubmed.ncbi.nlm.nih.gov/41380509/
       *****************************************************